• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸烟与年龄相关性黄斑变性。POLA研究。年龄相关性眼部病变。

Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liées à l'Age.

作者信息

Delcourt C, Diaz J L, Ponton-Sanchez A, Papoz L

机构信息

INSERM U 500, National Institute of Health and Medical Research, Montpellier, France.

出版信息

Arch Ophthalmol. 1998 Aug;116(8):1031-5. doi: 10.1001/archopht.116.8.1031.

DOI:10.1001/archopht.116.8.1031
PMID:9715683
Abstract

OBJECTIVE

To assess the associations between age-related macular degeneration (ARMD) and smoking.

METHODS

The POLA study is a population-based study taking place in the town of Sète, located on the French Mediterranean Sea border. The presence of early and late ARMD was assessed in 2196 participants on the basis of 50 degrees color fundus photographs using an international classification system.

RESULTS

After adjustment for age and sex, current and former smokers showed an increased prevalence of late ARMD (odds ratio [OR] = 3.6, 95% confidence interval [CI] = 1.1-12.4; OR = 3.2, 95% CI = 1.3-7.7, respectively). An increased risk was present in participants who smoked more than 20 pack-years (OR = 3.0, 95% CI = 0.9-9.5 for 20-39 pack-years; OR = 5.2, 95% CI = 2.0-13.6 for 40 pack-years and more). In addition, the risk of late ARMD remained increased until 20 years after cessation of smoking (OR = 9.0, 95% CI = 3.0-27.0 for 1-9 years; OR = 4.0, 95% CI = 1.3-12.0 for 10-19 years; OR = 1.3, 95% CI = 0.4-4.3 for 20 years and more). Smoking was not significantly associated with early signs of ARMD.

CONCLUSIONS

This study further confirms the adverse effect of tobacco on late ARMD. Former smokers seem to remain at high risk for ARMD.

摘要

目的

评估年龄相关性黄斑变性(ARMD)与吸烟之间的关联。

方法

POLA研究是一项基于人群的研究,在位于法国地中海沿岸的塞特镇开展。根据国际分类系统,基于50度彩色眼底照片对2196名参与者进行早期和晚期ARMD的评估。

结果

在对年龄和性别进行校正后,当前吸烟者和既往吸烟者晚期ARMD的患病率均有所增加(优势比[OR]=3.6,95%置信区间[CI]=1.1 - 12.4;OR = 3.2,95% CI = 1.3 - 7.7)。吸烟超过20包年的参与者风险增加(20 - 39包年,OR = 3.0,95% CI = 0.9 - 9.5;40包年及以上,OR = 5.2,95% CI = 2.0 - 13.6)。此外,戒烟后20年内晚期ARMD的风险仍然增加(戒烟1 - 9年,OR = 9.0,95% CI = 3.0 - 27.0;戒烟10 - 19年,OR = 4.0,95% CI = 1.3 - 12.0;戒烟20年及以上,OR = 1.3,95% CI = 0.4 - 4.3)。吸烟与ARMD的早期体征无显著关联。

结论

本研究进一步证实了烟草对晚期ARMD的不良影响。既往吸烟者似乎仍处于ARMD的高风险中。

相似文献

1
Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liées à l'Age.吸烟与年龄相关性黄斑变性。POLA研究。年龄相关性眼部病变。
Arch Ophthalmol. 1998 Aug;116(8):1031-5. doi: 10.1001/archopht.116.8.1031.
2
Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liées à l'Age (POLA) study.光照与年龄相关性黄斑变性风险:年龄相关性眼部病变(POLA)研究
Arch Ophthalmol. 2001 Oct;119(10):1463-8. doi: 10.1001/archopht.119.10.1463.
3
Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liées à l'Age.
Arch Ophthalmol. 1999 Oct;117(10):1384-90. doi: 10.1001/archopht.117.10.1384.
4
The three-year incidence of age-related macular degeneration: the "Pathologies Oculaires Liées à l'Age" (POLA) prospective study.年龄相关性黄斑变性的三年发病率:“与年龄相关的眼部病变”(POLA)前瞻性研究。
Am J Ophthalmol. 2005 Nov;140(5):924-6. doi: 10.1016/j.ajo.2005.05.002.
5
Associations of antioxidant enzymes with cataract and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liées à l'Age.抗氧化酶与白内障及年龄相关性黄斑变性的关联。POLA研究。年龄相关性眼部疾病。
Ophthalmology. 1999 Feb;106(2):215-22. doi: 10.1016/s0161-6420(99)90059-3.
6
Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study. Pathologies Oculaires Liées à l'Age.皮质性、核性和后囊下白内障的危险因素:POLA研究。年龄相关性眼病。
Am J Epidemiol. 2000 Mar 1;151(5):497-504. doi: 10.1093/oxfordjournals.aje.a010235.
7
Light exposure and the risk of cortical, nuclear, and posterior subcapsular cataracts: the Pathologies Oculaires Liées à l'Age (POLA) study.光照与皮质性、核性和后囊下白内障的风险:年龄相关性眼病(POLA)研究
Arch Ophthalmol. 2000 Mar;118(3):385-92. doi: 10.1001/archopht.118.3.385.
8
Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study.心血管疾病及其危险因素与年龄相关性黄斑变性的关联:POLA研究
Ophthalmic Epidemiol. 2001 Sep;8(4):237-49. doi: 10.1076/opep.8.4.237.1613.
9
Cigarette smoking and age-related macular degeneration.吸烟与年龄相关性黄斑变性
Optom Vis Sci. 1998 Jul;75(7):476-84. doi: 10.1097/00006324-199807000-00015.
10
Further observations on the association between smoking and the long-term incidence and progression of age-related macular degeneration: the Beaver Dam Eye Study.吸烟与年龄相关性黄斑变性的长期发病率及病情进展之间关联的进一步观察:比弗迪姆眼研究
Arch Ophthalmol. 2008 Jan;126(1):115-21. doi: 10.1001/archopht.126.1.115.

引用本文的文献

1
Diagnostic testing in the genetically complex age-related macular degeneration.基因复杂型年龄相关性黄斑变性的诊断检测
Med Genet. 2025 Feb 12;37(1):27-35. doi: 10.1515/medgen-2024-2064. eCollection 2025 Apr.
2
Different Therapeutic Approaches for Dry and Wet AMD.干性和湿性年龄相关性黄斑变性的不同治疗方法。
Int J Mol Sci. 2024 Dec 4;25(23):13053. doi: 10.3390/ijms252313053.
3
Pathologic vs. protective roles of hypoxia-inducible factor 1 in RPE and photoreceptors in wet vs. dry age-related macular degeneration.低氧诱导因子 1 在湿性与干性年龄相关性黄斑变性的 RPE 和光感受器中的病理性与保护性作用。
Proc Natl Acad Sci U S A. 2023 Dec 12;120(50):e2302845120. doi: 10.1073/pnas.2302845120. Epub 2023 Dec 6.
4
Bruch's Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration.布鲁赫膜:年龄相关性黄斑变性基于补体疗法的关键考量因素
J Clin Med. 2023 Apr 14;12(8):2870. doi: 10.3390/jcm12082870.
5
A Clinical and Preclinical Assessment of Clinical Trials for Dry Age-Related Macular Degeneration.干性年龄相关性黄斑变性临床试验的临床与临床前评估
Ophthalmol Sci. 2022 Aug 19;2(4):100213. doi: 10.1016/j.xops.2022.100213. eCollection 2022 Dec.
6
An Exploratory Study Provides Insights into MMP9 and Aβ Levels in the Vitreous and Blood across Different Ages and in a Subset of AMD Patients.一项探索性研究深入了解了不同年龄段和 AMD 患者亚组的玻璃体液和血液中 MMP9 和 Aβ 水平。
Int J Mol Sci. 2022 Nov 23;23(23):14603. doi: 10.3390/ijms232314603.
7
Incidence and Prevalence of Neovascular Age-Related Macular Degeneration in France between 2008 and 2018: The LANDSCAPE Study.2008年至2018年法国新生血管性年龄相关性黄斑变性的发病率和患病率:景观研究
Ophthalmol Sci. 2022 Jan 22;2(1):100114. doi: 10.1016/j.xops.2022.100114. eCollection 2022 Mar.
8
Smoking Cessation May Reduce Risk of Visual Field Progression in Heavy Smokers.戒烟可能降低重度吸烟者视野进展的风险。
J Glaucoma. 2022 Oct 1;31(10):796-803. doi: 10.1097/IJG.0000000000002092. Epub 2022 Aug 2.
9
Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities.抗 VEGF 治疗在新生血管性 AMD 中的不完全反应:探索疾病机制和治疗机会。
Prog Retin Eye Res. 2021 May;82:100906. doi: 10.1016/j.preteyeres.2020.100906. Epub 2020 Oct 3.
10
Effects of Smoking on Outcomes of Antivascular Endothelial Growth Factor Therapy in Patients with Neovascular Age-Related Macular Degeneration Smoking and Anti-VEGF Therapy in nAMD.吸烟对新生血管性年龄相关性黄斑变性患者抗血管内皮生长因子治疗结局的影响:年龄相关性黄斑变性中的吸烟与抗VEGF治疗
J Ophthalmol. 2018 Nov 12;2018:2353428. doi: 10.1155/2018/2353428. eCollection 2018.